[{"id":"776eb7f9-adf5-46d4-8cef-d2bc4c10c7d9","acronym":"","url":"https://clinicaltrials.gov/study/NCT03605199","created_at":"2023-06-15T16:08:15.111Z","updated_at":"2024-07-02T16:36:56.577Z","phase":"Phase 2","brief_title":"Denosumab in Subjects With Giant Cell Rich Tumors of Bone","source_id_and_acronym":"NCT03605199","lead_sponsor":"Leiden University Medical Center","biomarkers":" GCG","pipe":"","alterations":" ","tags":["GCG"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Prolia (denosumab)"],"overall_status":"Recruiting","enrollment":" Enrollment 60","initiation":"Initiation: 06/18/2018","start_date":" 06/18/2018","primary_txt":" Primary completion: 06/01/2021","primary_completion_date":" 06/01/2021","study_txt":" Completion: 06/01/2023","study_completion_date":" 06/01/2023","last_update_posted":"2019-08-26"}]